Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Halozyme Therapeutics, Inc.
| Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1,245.17 |
1,480.60 |
1,700.83 |
1,965.75 |
1,817.90 |
| Przychód Δ r/r |
0.00% |
18.91% |
14.88% |
15.58% |
-7.52% |
| Przychód (min) |
1,234.71 |
1,219.47 |
1,700.83 |
1,804.96 |
1,669.21 |
| Przychód (max) |
1,266.10 |
1,590.00 |
1,700.83 |
2,053.01 |
1,898.59 |
| EBITDA (średnia) |
703.66 |
836.70 |
961.16 |
1,110.87 |
1,027.31 |
| EBIT (średnia) |
634.76 |
754.78 |
867.05 |
1,002.10 |
926.73 |
| EBIT % |
50.98% |
50.98% |
50.98% |
50.98% |
50.98% |
| Zysk netto (średni) |
692.91 |
810.93 |
1,138.44 |
1,296.18 |
1,165.46 |
| Zysk netto % |
55.65% |
54.77% |
66.93% |
65.94% |
64.11% |
| EPS (średnia) |
5.35 |
7.16 |
9.02 |
10.02 |
9.01 |
| Liczba analityków (Przychody) |
5 |
7 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
5 |
4 |
1 |
1 |
1 |
| symbol |
HALO |
HALO |
HALO |
HALO |
HALO |